Phoenixville, PA, United States of America

Hua-Poo Su

USPTO Granted Patents = 8 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Hua-Poo Su: Advancing Healthcare with Innovative Patents

Introduction:

Meet Hua-Poo Su, a talented inventor based in Phoenixville, PA, who has made significant contributions to the field of healthcare through his innovative patents. As a member of the renowned pharmaceutical company Merck Sharp & Dohme Corporation, Su's inventions and discoveries have paved the way for advancements in immunotherapy, particularly in combating the human respiratory syncytial virus (RSV).

Latest Patents:

Su's latest patents revolve around the development of monoclonal antibodies with high anti-RSV neutralizing titers. These antibodies have demonstrated promising potential in diagnostic, prophylactic, and therapeutic applications. The isolated nucleic acids encoding these antibodies, along with the host cells transformed by them, have opened doors to a new realm of passive immunotherapy specifically aimed at infants and the elderly.

Career Highlights:

With an impressive portfolio of six granted patents, Su has proven to be a driving force behind medical innovation. His work not only addresses significant healthcare challenges but also contributes to the scientific community's understanding of immunology and infectious diseases. Su's patents on antibody-neutralizing RSV not only demonstrate his expertise but also reflect his commitment to improving patient outcomes and quality of life.

Collaborations:

Within the Merck Sharp & Dohme Corporation, Su has collaborated with esteemed colleagues such as Kalpit A Vora and Kara S Cox. Through these collaborations, Su has harnessed the power of teamwork and collective expertise to approach complex challenges in the field of healthcare. This collaborative spirit has undoubtedly led to the development of groundbreaking inventions that may have a substantial impact on medical treatments and outcomes.

Conclusion:

Hua-Poo Su's dedication and innovation in the field of healthcare have made a profound impact on the fight against the human respiratory syncytial virus. His patents on monoclonal antibodies and the accompanying diagnostic, prophylactic, and therapeutic methods offer hope for more effective treatments. As an esteemed inventor and a valued member of the Merck Sharp & Dohme Corporation, Su continues to spearhead advancements in immunotherapy, paving the way for a healthier future.

Disclaimer: The information provided above is based on the available data at the time of writing and may be subject to change or update. For the latest and most accurate information about Hua-Poo Su's patents and career, please refer to credible sources and Merck Sharp & Dohme Corporation's official communications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…